High frequency of hand foot syndrome with capecitabine
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2010; 20 (6): 421-422
em Inglês
| IMEMR
| ID: emr-98109
ABSTRACT
A hospital based cross-sectional retrospective study was conducted to determine the frequency of hand foot syndrome [HFS] with Capecitabine as a single agent and in combination with Oxaliplatin. The study included 43 consecutive cases of colorectal carcinoma and conducted from June till December 2008. Patients on palliative care were excluded. SPSS was used for the application of chi-square test, by keeping the level of significance as p<0.05. Fifteen [34.9%] patients developed HFS, 10 in the single-agent and 5 in the combination group. No significant association of HFS with either regimens was noted [p=0.876]
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Síndrome
/
Neoplasias Colorretais
/
Estudos Transversais
/
Quimioterapia Combinada
/
Dermatoses da Mão
/
Antimetabólitos Antineoplásicos
Tipo de estudo:
Estudo de prevalência
Limite:
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
J. Coll. Physicians Surg. Pak.
Ano de publicação:
2010
Similares
MEDLINE
...
LILACS
LIS